Lv1
44 积分 2023-12-19 加入
New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications
3个月前
已完结
Validation of an LC–MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma
11个月前
已关闭
Measurement of the Direct Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Plasma Using Turbulent Flow Liquid Chromatography With High-Resolution Mass Spectrometry
1年前
已完结
A synergy of liquid chromatography with high‐resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes
1年前
已完结
Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma
1年前
已完结
Betrixaban (PRT054021): pharmacology, Dose Selection and Clinical Studies
1年前
已完结
Betrixaban (PRT054021): pharmacology, Dose Selection and Clinical Studies
1年前
已关闭
Investigating Betrixaban Maleate drug degradation profiles, isolation and characterization of unknown degradation products by mass-triggered preparative HPLC, HRMS, and NMR
1年前
已完结
Routine Therapeutic Drug Monitoring of Dabigatran: Experience at a Tertiary Center
1年前
已完结
皖公网安备34019202002308
